ECSP961736A - TREATMENT METHOD - Google Patents

TREATMENT METHOD

Info

Publication number
ECSP961736A
ECSP961736A ECSP961736A ECSP961736A EC SP961736 A ECSP961736 A EC SP961736A EC SP961736 A ECSP961736 A EC SP961736A EC SP961736 A ECSP961736 A EC SP961736A
Authority
EC
Ecuador
Prior art keywords
treatment method
treatment
ratio
aqueous liquid
dosing regimen
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Richard Peregrine Bax
Mike Gale Ramsey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42042466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP961736(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to ECSP961736 priority Critical patent/ECSP961736A/en
Publication of ECSP961736A publication Critical patent/ECSP961736A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proporcionan formulaciones pediátricas en forma de suspensión líquida acuosa que contienen amoxicilina trihidrato y clavulanato potásico en una proporción desde 6:1 hasta 8:1 para su utilización en un régimen de dosificación BID para el tratamiento de infecciones bacterianas.Pediatric formulations in the form of an aqueous liquid suspension containing amoxicillin trihydrate and potassium clavulanate in a ratio of 6: 1 to 8: 1 are provided for use in a BID dosing regimen for the treatment of bacterial infections.

ECSP961736 1996-04-30 1996-04-30 TREATMENT METHOD ECSP961736A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961736 ECSP961736A (en) 1996-04-30 1996-04-30 TREATMENT METHOD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961736 ECSP961736A (en) 1996-04-30 1996-04-30 TREATMENT METHOD

Publications (1)

Publication Number Publication Date
ECSP961736A true ECSP961736A (en) 1997-10-03

Family

ID=42042466

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961736 ECSP961736A (en) 1996-04-30 1996-04-30 TREATMENT METHOD

Country Status (1)

Country Link
EC (1) ECSP961736A (en)

Similar Documents

Publication Publication Date Title
ES2180251T3 (en) COMPRESSED COVERED WITH POLYMER, CONTAINING AMOXYCLINE AND CLAVULANATE.
BRPI0009719B8 (en) treatment process
ES2183841T3 (en) DOSAGE FORMS TO ADMINISTER A FARMASCO IN A LQUIDID FORMULATION.
EP1093812A3 (en) Amoxycillin and clavulanate containing pharmaceutical formulation
NO20016198L (en) Oral pharmaceutical compositions containing taxanes and methods for using the same in treatment
ES2191682T3 (en) NEW PHARMACEUTICAL FORMULATION.
DE69520882T2 (en) MEDICINAL PREPARATION CONTAINING AMOXYCILLIN AND POTASSIUM CLAVUNALATE
SE9503143D0 (en) New preparation
EA199700354A1 (en) Composition comprising amoxycillin and clavulanic acid
NZ514248A (en) Pharmaceutical composition in a unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
ATE164159T1 (en) SUBSTITUTED TRIOLO
DE69928815D1 (en) DOSAGE FORM WITH LIQUID FORMULATION
IT8248964A0 (en) MIXED GRANULAR FORMULATION WITH LONG ACTION, PARTICULARLY FOR THE ORAL ADMINISTRATION OF ANTIBIOTICS
ID15895A (en) FORMULATION TO REDUCE BLOOD CHOLESTEROLS AND ABSORPTION OF FUNCTION OF FATS
TR200103125T2 (en) Anticonvulsant derivatives for use in improving autism.
DK0391185T3 (en) 1,8-naphthyridines
ITRM930286A0 (en) PHARMACEUTICAL COMPOSITION FOR RECTAL ADMINISTRATION IN THE TREATMENT OF HEADACHE AND RELATED METHOD OF PREPARATION AND USE.
ECSP961736A (en) TREATMENT METHOD
CL2004000496A1 (en) PHARMACEUTICAL COMPOSITION LIQUID ORAL ADMINISTRATION THAT INCLUDES WATER, METHYL ACID-2- (2'-CHLORINE-6'-FLUOROANILINO) PHENYLACETIC, AND A SUSPENSION AGENT, WITH A PH BETWEEN 4.5 AND 5.5; PREPARATION METHOD; USE TO TREAT A DEPENDENT DISORDER
IT1291895B1 (en) FLUID PHARMACEUTICAL PREPARATION BASED ON NIMESULIDE FOR ORAL AND RHINOPHARYNGAL USE
IT8219012A0 (en) METHOD FOR THE ORAL ADMINISTRATION OF SUBSTANCES IN THE FORM OF LIPOSOMES, AND RELATED PHARMACEUTICAL FORMULATIONS.
MX9708383A (en) Composition comprising amoxycillin and clavulanic acid.
ES2157888T3 (en) VETERINARY TREATMENT.
CA2220103A1 (en) Composition comprising amoxycillin and clavulanic acid
IT1263143B (en) PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN